Acute Erythroid Leukemia (AEL) Latest Advances

Clinical analysis of 3 cases of childhood primary pure erythroid leukemia and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Acute erythroid leukaemia transformation in polycythaemia vera with leukemic involvement in liver and ascites.

Journal: BMJ case reports

Published: August 03, 2026

Study of Cytotoxicity of Pyrrolo[3,4-d]isoxazoline and Pyrrolo[2,1-a]isoquinoline Derivatives Against Tumor Cell Lines.

Journal: International journal of molecular sciences

Published: June 13, 2026

Linezolid Acts as a Selective Inhibitor of the JAK2 V617F Mutation.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Prdx2 suppresses the erythroid differentiation by modulating the ROS-JNK1 signaling axis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 20, 2026

Clinical characteristics and prognostic analysis of acute erythroid leukemia

Journal: Zhonghua nei ke za zhi

Published: May 08, 2026

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Journal: Biochemical pharmacology

Published: April 21, 2026

Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.

Journal: Journal of hematopathology

Published: April 13, 2026

Interferon Receptor Chain Deficiency in Murine Friend Erythroleukemia Cell Clone Resistant to Type I or Type I and II Interferons.

Journal: International journal of molecular sciences

Published: March 05, 2026

MiR-513a promotes human erythroid differentiation by modulating c-Jun.

Journal: FEBS open bio

Published: January 07, 2026

The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.

Journal: Chemico-biological interactions

Published: December 28, 2025

Dataset reporting the differential effect of HNRNPA1 isoforms on alternative splicing.

Journal: Data in brief

Published: October 15, 2025

Acute Erythroid Leukemia (AEL) Latest Advances

Find the Latest Research About Acute Erythroid Leukemia (AEL)

Clinical analysis of 3 cases of childhood primary pure erythroid leukemia and literature review

Clinical analysis of 3 cases of childhood primary pure erythroid leukemia and literature review

Acute erythroid leukaemia transformation in polycythaemia vera with leukemic involvement in liver and ascites.

Acute erythroid leukaemia transformation in polycythaemia vera with leukemic involvement in liver and ascites.

Study of Cytotoxicity of Pyrrolo[3,4-d]isoxazoline and Pyrrolo[2,1-a]isoquinoline Derivatives Against Tumor Cell Lines.

Study of Cytotoxicity of Pyrrolo[3,4-d]isoxazoline and Pyrrolo[2,1-a]isoquinoline Derivatives Against Tumor Cell Lines.

Linezolid Acts as a Selective Inhibitor of the JAK2 V617F Mutation.

Linezolid Acts as a Selective Inhibitor of the JAK2 V617F Mutation.

Prdx2 suppresses the erythroid differentiation by modulating the ROS-JNK1 signaling axis.

Prdx2 suppresses the erythroid differentiation by modulating the ROS-JNK1 signaling axis.

Clinical characteristics and prognostic analysis of acute erythroid leukemia

Clinical characteristics and prognostic analysis of acute erythroid leukemia

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.

Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.

Interferon Receptor Chain Deficiency in Murine Friend Erythroleukemia Cell Clone Resistant to Type I or Type I and II Interferons.

Interferon Receptor Chain Deficiency in Murine Friend Erythroleukemia Cell Clone Resistant to Type I or Type I and II Interferons.

MiR-513a promotes human erythroid differentiation by modulating c-Jun.

MiR-513a promotes human erythroid differentiation by modulating c-Jun.

The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.

The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.

Dataset reporting the differential effect of HNRNPA1 isoforms on alternative splicing.

Dataset reporting the differential effect of HNRNPA1 isoforms on alternative splicing.